Amlodipine/atorvastatin

Amlodipine/atorvastatin, sold under the brand name Caduet among others, is a fixed-dose combination medication for the treatment of high cholesterol and high blood pressure. It contains a statin and a calcium channel blocker.[1][2]

Society and culture

Brand names

Amlodipine/atorvastatin is marketed under the brand name Caduet in the United States, Australia, and Russia, and Envacar in the Philippines.[3][4]

In some countries Caduet is marketed by Viatris after Upjohn was spun off from Pfizer.[5][6][7]

References

  1. Monique P. Curran. Amlodipine/Atorvastatin Drugs, Springer Science+Business Media, 2010^
  2. Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives Vascular Health and Risk Management, 2009^
  3. Caduet - Drugs.com^
  4. Envacar - Drugs.com^
  5. Pfizer Completes Transaction to Combine Its Upjohn Business with Mylan Pfizer, 16 November 2020, retrieved 17 June 2024^
  6. Caduet Pfizer, retrieved 17 June 2024^
  7. Brands Viatris, 16 November 2020, retrieved 17 June 2024^